Recording and assessment of medication errors : Experience of the Drug Commission of the German Medical Association

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
Ursula KöberleKatrin Bräutigam

Abstract

Adverse drug reactions (ADRs) are a common problem in daily clinical practice and they may in part result from medication errors. According to the extended interpretation in the new European pharmacovigilance guideline, medication error-related reactions are classified as ADRs. Therefore, the pharmacovigilance system needs to be adjusted to record medication errors. As a partner in the German pharmacovigilance system, the Drug Commission of the German Medical Association (DCGMA) has set up a project for developing a subsystem for the recording and assessment of medication errors within the existing spontaneous reporting system for ADRs. The aim of the project was to evaluate the feasibility of recording and assessing medication errors within the existing structures and to investigate whether it is possible to deduce risk-reducing strategies from the information obtained by the case reports. In the present narrative review, the experience of the DCGMA with the recording and assessment of medication errors is described. The conclusions and recommendations from the analysis of the reports of medication errors show how they can be used to improve medication safety. The project has closed a gap in pharmacovigilance.

References

Mar 17, 2000·BMJ : British Medical Journal·J Reason
Mar 26, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Harald DormannKay Brune
May 19, 2004·Journal of Internal Medicine·H DormannE G Hahn
Jul 8, 2008·European Journal of Clinical Pharmacology·Y ZopfH Dormann
Aug 19, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Yurdaguel ZopfHarald Dormann
Jun 27, 2009·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Vicky Borders-Hemphill
Mar 9, 2011·Pharmacoepidemiology and Drug Safety·Dominik RottenkolberUNKNOWN Net of Regional Pharmacovigilance Centers
Oct 4, 2011·International Journal of Clinical Pharmacology and Therapeutics·C Hofer-DueckelmannJ Schuler
Dec 12, 2012·PloS One·Ruairi M GallagherRosalind L Smyth
May 25, 2013·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·I PelzW Ahrens
Jul 4, 2013·Nature Communications·Mark C UrbanDaniel I Bolnick
Sep 18, 2013·British Journal of Clinical Pharmacology·Thomas BürkleRenke Maas
May 2, 2014·Journal of Clinical Pharmacology·Saskia Huckels-Baumgart, Tanja Manser
Jun 18, 2014·Pharmacoepidemiology and Drug Safety·Florian MeierHarald Dormann
Dec 30, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Raja BenkiraneShanti N Pal
Jul 28, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Mulugeta Tarekegn AngamoLuke R E Bereznicki
Mar 3, 2017·European Journal of Clinical Pharmacology·T J OscanoaAlfonso Carvajal

❮ Previous
Next ❯

Citations

Jun 24, 2021·Das Gesundheitswesen·Christoph StrumannJost Steinhäuser

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.